Chronic myelogenous leukemia

Results: 283



#Item
51Haematology Clinical Trials The Department of Haematology at Flinders Medical Centre has a Clinical Trials Unit for research into the diagnosis, monitoring, and treatment of haematological disorders. This includes both b

Haematology Clinical Trials The Department of Haematology at Flinders Medical Centre has a Clinical Trials Unit for research into the diagnosis, monitoring, and treatment of haematological disorders. This includes both b

Add to Reading List

Source URL: www.fcic.org.au

Language: English - Date: 2014-02-25 19:14:38
52Honours Projects 2014 – Pharmacology Pharmacogenomics and pharmacokinetics of tyrosine kinase inhibitors in leukaemia Project Background Several pharmacogenomic studies are likely to be offered for 2013 in

Honours Projects 2014 – Pharmacology Pharmacogenomics and pharmacokinetics of tyrosine kinase inhibitors in leukaemia Project Background Several pharmacogenomic studies are likely to be offered for 2013 in

Add to Reading List

Source URL: health.adelaide.edu.au

Language: English - Date: 2013-09-25 02:05:52
53Hindawi Publishing Corporation Case Reports in Hematology Volume 2014, Article ID[removed], 5 pages http://dx.doi.org[removed][removed]Case Report

Hindawi Publishing Corporation Case Reports in Hematology Volume 2014, Article ID[removed], 5 pages http://dx.doi.org[removed][removed]Case Report

Add to Reading List

Source URL: downloads.hindawi.com

Language: English - Date: 2014-11-16 08:28:07
54Hindawi Publishing Corporation Case Reports in Hematology Volume 2015, Article ID[removed], 5 pages http://dx.doi.org[removed][removed]Case Report

Hindawi Publishing Corporation Case Reports in Hematology Volume 2015, Article ID[removed], 5 pages http://dx.doi.org[removed][removed]Case Report

Add to Reading List

Source URL: downloads.hindawi.com

Language: English - Date: 2015-02-18 01:28:07
55Citation: Cell Death and Disease[removed], e373; doi:[removed]cddis[removed] & 2012 Macmillan Publishers Limited All rights reserved[removed]www.nature.com/cddis Apoptosis and autophagy have opposite roles on

Citation: Cell Death and Disease[removed], e373; doi:[removed]cddis[removed] & 2012 Macmillan Publishers Limited All rights reserved[removed]www.nature.com/cddis Apoptosis and autophagy have opposite roles on

Add to Reading List

Source URL: www.nature.com

Language: English - Date: 2012-08-16 10:01:17
56HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use TASIGNA safely and effectively. See full prescribing information for TASIGNA. •

HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use TASIGNA safely and effectively. See full prescribing information for TASIGNA. •

Add to Reading List

Source URL: www.accessdata.fda.gov

Language: English - Date: 2015-01-28 10:58:59
57Chemistry / Piperazines / Orphan drugs / Pyridines / Quality use of medicines / Pharmaceutical Benefits Scheme / Chronic myelogenous leukemia / Dasatinib / Tyrosine-kinase inhibitor / Organic chemistry / Medicine / Pyrimidines

The Drug Utilisation Sub-Committee (DUSC) of the Pharmaceutical Benefits Advisory Committee (PBAC) held its 80th meeting on 6 February[removed]DUSC is a national focus of excellence in collecting, analysing and interpretin

Add to Reading List

Source URL: www.pbs.gov.au

Language: English - Date: 2015-03-13 00:20:02
58LC Paper No. CB[removed]) 7 March 2005 Dear Legislative Councillors, Subject: Standard Drug Formulary and Public Healthcare System On behalf of Chronic Myeloid Leukaemia (CML) and Gastrointestinal Stromal Tumour (

LC Paper No. CB[removed]) 7 March 2005 Dear Legislative Councillors, Subject: Standard Drug Formulary and Public Healthcare System On behalf of Chronic Myeloid Leukaemia (CML) and Gastrointestinal Stromal Tumour (

Add to Reading List

Source URL: www.legco.gov.hk

Language: English - Date: 2005-10-19 22:47:56
59Drug Utilisation Sub-Committee Outcome Statement 6 February 2014 The Drug Utilisation Sub-Committee (DUSC) of the Pharmaceutical Benefits Advisory Committee (PBAC) held its 80th meeting on 6 February[removed]DUSC is a nati

Drug Utilisation Sub-Committee Outcome Statement 6 February 2014 The Drug Utilisation Sub-Committee (DUSC) of the Pharmaceutical Benefits Advisory Committee (PBAC) held its 80th meeting on 6 February[removed]DUSC is a nati

Add to Reading List

Source URL: www.pbs.gov.au

Language: English - Date: 2015-03-13 00:20:02
60Microsoft Word - FINAL CML Report dated 28 September 04.doc

Microsoft Word - FINAL CML Report dated 28 September 04.doc

Add to Reading List

Source URL: www.otago.ac.nz

Language: English